Variant report

Variant	esv3514391
Chromosome Location	chr6:150642309-150649007
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr6:150644374-150644606	K562	blood:	n/a	n/a
2	ARID3A	chr6:150648358-150648558	K562	blood:	n/a	n/a
3	BHLHE40	chr6:150644360-150644691	K562	blood:	n/a	n/a
4	BHLHE40	chr6:150648590-150648641	K562	blood:	n/a	n/a
5	CCNT2	chr6:150644328-150644856	K562	blood:	n/a	n/a
6	CEBPB	chr6:150644234-150644757	K562	blood:	n/a	chr6:150644471-150644480 chr6:150644471-150644480 chr6:150644469-150644482 chr6:150644469-150644480 chr6:150644471-150644480 chr6:150644471-150644480
7	CEBPB	chr6:150644288-150644668	IMR90	lung:	n/a	chr6:150644471-150644480 chr6:150644471-150644480 chr6:150644469-150644482 chr6:150644469-150644480 chr6:150644471-150644480 chr6:150644471-150644480
8	CEBPB	chr6:150643557-150643916	HepG2	liver:	n/a	chr6:150643730-150643739 chr6:150643729-150643740 chr6:150643728-150643741
9	CEBPB	chr6:150643545-150643910	K562	blood:	n/a	chr6:150643730-150643739 chr6:150643729-150643740 chr6:150643728-150643741
10	CEBPB	chr6:150644288-150644667	HepG2	liver:	n/a	chr6:150644471-150644480 chr6:150644471-150644480 chr6:150644469-150644482 chr6:150644469-150644480 chr6:150644471-150644480 chr6:150644471-150644480
11	CEBPB	chr6:150644348-150644705	A549	lung:	n/a	chr6:150644471-150644480 chr6:150644471-150644480 chr6:150644469-150644482 chr6:150644469-150644480 chr6:150644471-150644480 chr6:150644471-150644480
12	CEBPB	chr6:150644307-150644671	Hela-S3	cervix:	n/a	chr6:150644471-150644480 chr6:150644471-150644480 chr6:150644469-150644482 chr6:150644469-150644480 chr6:150644471-150644480 chr6:150644471-150644480
13	CEBPB	chr6:150644183-150644674	A549	lung:	n/a	chr6:150644471-150644480 chr6:150644471-150644480 chr6:150644469-150644482 chr6:150644469-150644480 chr6:150644471-150644480 chr6:150644471-150644480
14	CEBPB	chr6:150644140-150644809	HCT-116	colon:	n/a	chr6:150644471-150644480 chr6:150644471-150644480 chr6:150644469-150644482 chr6:150644469-150644480 chr6:150644471-150644480 chr6:150644471-150644480
15	CEBPB	chr6:150643604-150643721	H1-hESC	embryonic stem cell:	n/a	n/a
16	CEBPB	chr6:150644290-150644662	A549	lung:	n/a	chr6:150644471-150644480 chr6:150644471-150644480 chr6:150644469-150644482 chr6:150644469-150644480 chr6:150644471-150644480 chr6:150644471-150644480
17	CEBPB	chr6:150644185-150644801	ECC-1	luminal epithelium:	n/a	chr6:150644471-150644480 chr6:150644471-150644480 chr6:150644469-150644482 chr6:150644469-150644480 chr6:150644471-150644480 chr6:150644471-150644480
18	CEBPB	chr6:150644223-150644687	K562	blood:	n/a	chr6:150644471-150644480 chr6:150644471-150644480 chr6:150644469-150644482 chr6:150644469-150644480 chr6:150644471-150644480 chr6:150644471-150644480
19	CEBPB	chr6:150644380-150644520	HepG2	liver:	n/a	chr6:150644471-150644480 chr6:150644471-150644480 chr6:150644469-150644482 chr6:150644469-150644480 chr6:150644471-150644480 chr6:150644471-150644480
20	CEBPB	chr6:150644337-150644550	HepG2	liver:	n/a	chr6:150644471-150644480 chr6:150644471-150644480 chr6:150644469-150644482 chr6:150644469-150644480 chr6:150644471-150644480 chr6:150644471-150644480
21	CEBPB	chr6:150644135-150644819	MCF-7	breast:	n/a	chr6:150644471-150644480 chr6:150644471-150644480 chr6:150644469-150644482 chr6:150644469-150644480 chr6:150644471-150644480 chr6:150644471-150644480
22	CEBPB	chr6:150644310-150644748	MCF-7	breast:	n/a	chr6:150644471-150644480 chr6:150644471-150644480 chr6:150644469-150644482 chr6:150644469-150644480 chr6:150644471-150644480 chr6:150644471-150644480
23	CEBPB	chr6:150644273-150644665	H1-hESC	embryonic stem cell:	n/a	chr6:150644471-150644480 chr6:150644471-150644480 chr6:150644469-150644482 chr6:150644469-150644480 chr6:150644471-150644480 chr6:150644471-150644480
24	CEBPB	chr6:150644193-150644767	K562	blood:	n/a	chr6:150644471-150644480 chr6:150644471-150644480 chr6:150644469-150644482 chr6:150644469-150644480 chr6:150644471-150644480 chr6:150644471-150644480
25	CEBPB	chr6:150643562-150643891	MCF-7	breast:	n/a	chr6:150643730-150643739 chr6:150643729-150643740 chr6:150643728-150643741
26	CEBPB	chr6:150643567-150643852	K562	blood:	n/a	chr6:150643730-150643739 chr6:150643729-150643740 chr6:150643728-150643741
27	CEBPB	chr6:150644243-150644698	ECC-1	luminal epithelium:	n/a	chr6:150644471-150644480 chr6:150644471-150644480 chr6:150644469-150644482 chr6:150644469-150644480 chr6:150644471-150644480 chr6:150644471-150644480
28	CEBPB	chr6:150646083-150646753	ECC-1	luminal epithelium:	n/a	chr6:150646173-150646185
29	CEBPB	chr6:150644321-150644649	HepG2	liver:	n/a	chr6:150644471-150644480 chr6:150644471-150644480 chr6:150644469-150644482 chr6:150644469-150644480 chr6:150644471-150644480 chr6:150644471-150644480
30	CEBPD	chr6:150644359-150644546	HepG2	liver:	n/a	chr6:150644471-150644480 chr6:150644469-150644480
31	CEBPD	chr6:150644335-150644738	K562	blood:	n/a	chr6:150644471-150644480 chr6:150644469-150644480
32	CEBPD	chr6:150644232-150644737	K562	blood:	n/a	chr6:150644471-150644480 chr6:150644469-150644480
33	CHD2	chr6:150647949-150648274	K562	blood:	n/a	n/a
34	CUX1	chr6:150643250-150643280	K562	blood:	n/a	n/a
35	CUX1	chr6:150644179-150644518	K562	blood:	n/a	n/a
36	E2F4	chr6:150646461-150646593	MCF10A-Er-Src	breast:	n/a	n/a
37	EBF1	chr6:150645966-150646161	GM12878	blood:	n/a	chr6:150646075-150646086 chr6:150646074-150646087 chr6:150645998-150646007 chr6:150645997-150646007
38	EP300	chr6:150645060-150645682	ECC-1	luminal epithelium:	n/a	n/a
39	EP300	chr6:150644266-150644689	K562	blood:	n/a	n/a
40	EP300	chr6:150648338-150648655	K562	blood:	n/a	n/a
41	EP300	chr6:150645059-150646945	ECC-1	luminal epithelium:	n/a	chr6:150646251-150646267
42	EP300	chr6:150645966-150646890	ECC-1	luminal epithelium:	n/a	chr6:150646251-150646267
43	ESR1	chr6:150645157-150645569	ECC-1	luminal epithelium:	n/a	n/a
44	ESR1	chr6:150646012-150646673	ECC-1	luminal epithelium:	n/a	n/a
45	ESR1	chr6:150646084-150646662	ECC-1	luminal epithelium:	n/a	n/a
46	ESR1	chr6:150645197-150645679	ECC-1	luminal epithelium:	n/a	n/a
47	ESR1	chr6:150645115-150645564	ECC-1	luminal epithelium:	n/a	n/a
48	ESR1	chr6:150646029-150646693	ECC-1	luminal epithelium:	n/a	n/a
49	FOS	chr6:150646443-150646504	MCF10A-Er-Src	breast:	n/a	n/a
50	FOXM1	chr6:150645976-150646850	ECC-1	luminal epithelium:	n/a	n/a

No.	Distal block	Cell Line	Cell type
1	chr6:150630670..150634449-chr6:150639443..150643580,5	K562	blood:
2	chr6:150514785..150516493-chr6:150643803..150645499,2	K562	blood:
3	chr12:120729257..120730114-chr6:150647863..150648380,2	Hela-S3	cervix:
4	chr6:150637450..150641855-chr6:150642003..150645154,6	K562	blood:
5	chr6:150586437..150588677-chr6:150642579..150644863,2	K562	blood:
6	chr6:150646137..150648585-chr6:150648675..150650937,2	MCF-7	breast:
7	chr6:150638163..150639671-chr6:150643884..150646332,2	MCF-7	breast:
8	chr6:150644840..150646705-chr6:150652961..150654511,2	K562	blood:
9	chr6:150642390..150644728-chr6:150645013..150646951,2	K562	blood:
10	chr6:150642041..150644950-chr6:150645013..150647968,3	K562	blood:
11	chr6:150642390..150644728-chr6:150645013..150646951,2	K562	blood:
12	chr6:150500428..150502661-chr6:150644242..150645820,2	K562	blood:

Variant related genes	Relation type
RNU4-7P	TF binding region
ENSG00000201628	chromatin interactions
ENSG00000202538	chromatin interactions

Extended variants
information (count: 287 )
Associated
traits (count: 83 )

Variant overlapped rSNPs/rCNVs (count:287 , 50 per page) page: 1 2 3 4 5 6

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs527796453	chr6:150642318-150642319	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
2	rs547616694	chr6:150642336-150642337	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
3	rs538281472	chr6:150642340-150642341	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
4	rs4478415	chr6:150642353-150642354	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
5	rs138589918	chr6:150642385-150642386	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
6	rs540895926	chr6:150642397-150642398	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
7	rs149310670	chr6:150642398-150642399	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
8	rs550482429	chr6:150642399-150642400	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
9	rs142728219	chr6:150642411-150642412	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
10	rs386707031	chr6:150642413-150642414	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
11	rs574104703	chr6:150642414-150642415	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
12	rs58254563	chr6:150642421-150642422	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
13	rs542719710	chr6:150642565-150642566	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
14	rs180877457	chr6:150642573-150642574	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
15	rs531304059	chr6:150642590-150642591	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
16	rs550992333	chr6:150642623-150642624	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
17	rs200581277	chr6:150642639-150642640	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
18	rs559540719	chr6:150642640-150642641	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
19	rs58767325	chr6:150642641-150642642	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
20	rs527594745	chr6:150642643-150642644	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
21	rs529978905	chr6:150642734-150642735	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
22	rs185899692	chr6:150642737-150642738	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
23	rs567454834	chr6:150642745-150642746	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
24	rs9384384	chr6:150642796-150642797	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
25	rs377637394	chr6:150642800-150642801	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
26	rs549938602	chr6:150642815-150642816	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
27	rs118043515	chr6:150642838-150642839	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
28	rs538319877	chr6:150642866-150642867	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
29	rs558200936	chr6:150642867-150642868	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
30	rs144602466	chr6:150642964-150642965	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
31	rs148491297	chr6:150642979-150642980	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
32	rs189164898	chr6:150642991-150642992	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
33	rs554132428	chr6:150643014-150643015	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
34	rs574269795	chr6:150643099-150643100	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
35	rs542901947	chr6:150643167-150643168	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
36	rs563078130	chr6:150643217-150643218	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
37	rs575763801	chr6:150643221-150643222	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
38	rs181572059	chr6:150643232-150643233	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
39	rs528561537	chr6:150643290-150643291	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
40	rs35985176	chr6:150643310-150643311	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
41	rs544667819	chr6:150643344-150643345	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
42	rs186261989	chr6:150643400-150643401	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
43	rs77854963	chr6:150643420-150643421	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
44	rs554392267	chr6:150643421-150643422	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
45	rs561068722	chr6:150643424-150643425	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
46	rs529997001	chr6:150643430-150643431	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
47	rs190717122	chr6:150643432-150643433	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
48	rs538365090	chr6:150643435-150643436	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
49	rs536868142	chr6:150643473-150643474	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
50	rs1890521	chr6:150643476-150643477	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a

Variant related diseases (count:83)

Disease	PMID	Source
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Biliary cancer	19435499	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Ewing''s sarcoma	17952124	CNVD
Autism	21448237	CNVD
Autism	22495311	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Neuroblastoma	18923191	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Melanoma	18172304	CNVD
Cancer	21637783	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	19010834	CNVD
Non-small cell lung cancer	21044232	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	16608533	CNVD
Non-small cell lung cancer	21385341	CNVD
Prostate cancer	16705090	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Colorectal cancer	16272173	CNVD
Ependymoma	16718352	CNVD
Gastric cancer	17908304	CNVD
High-proliferative meningiomas	17937814	CNVD
Intracranial tumor	16823260	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	16272173	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Follicular lymphoma	20505157	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Malignant melanoma	18718029	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Breast cancer	21858162	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	17603634	CNVD
Developmental delay	19490664	CNVD
Burkitt''s lymphoma	18698080	CNVD
Neurodevelopmental disorder	22521361	CNVD
small cell lung cancer	20016488	CNVD
Adenoid cystic carcinoma	18698036	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Leukemia	18688285	CNVD
Renal cell carcinoma	18592004	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Malignant melanoma	17260012	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Soft tissue tumor	16732325	CNVD
Burkitt''s lymphoma	19759907	CNVD
Esophageal cancer	21851588	CNVD
Cancer	17160897	CNVD
Breast cancer	17417639	CNVD
Breast cancer	17850661	CNVD
Renal cell carcinoma	18765545	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Breast cancer	17133270	CNVD
Breast cancer	21804112	CNVD
Myelofibrosis	22110671	CNVD
Ovarian neoplasms	16753589	CNVD
Retinoblastoma	22278416	CNVD
Breast cancer	20556506	CNVD
Hirschsprung''s Disease	21712996	CNVD
Testicular germ cell tumor	18059402	CNVD
Pancreatic cancer	17952125	CNVD
Developmental delay	21147756	CNVD

Chromatin state (count:102 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:150639600-150643200	Weak transcription	Lung	lung
2	chr6:150640600-150643400	Enhancers	Skeletal Muscle Male	skeletal muscle
3	chr6:150641200-150645000	Enhancers	K562	blood
4	chr6:150641800-150642800	Weak transcription	Adipose Nuclei	Adipose
5	chr6:150641800-150643200	Weak transcription	Fetal Muscle Trunk	muscle
6	chr6:150641800-150644400	Weak transcription	Left Ventricle	heart
7	chr6:150642000-150646200	Weak transcription	Breast Myoepithelial Primary Cells	Breast
8	chr6:150642000-150648200	Weak transcription	Aorta	Aorta
9	chr6:150642000-150648400	Weak transcription	Right Ventricle	heart
10	chr6:150642200-150642600	Weak transcription	Fetal Muscle Leg	muscle
11	chr6:150642200-150642600	Weak transcription	Psoas Muscle	Psoas
12	chr6:150642200-150642600	Weak transcription	Skeletal Muscle Female	skeletal muscle
13	chr6:150642200-150643000	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
14	chr6:150642200-150643600	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
15	chr6:150642600-150643200	Enhancers	Skeletal Muscle Female	skeletal muscle
16	chr6:150642600-150643200	Weak transcription	Spleen	Spleen
17	chr6:150642600-150646400	Enhancers	Fetal Muscle Leg	muscle
18	chr6:150642600-150647400	Enhancers	Psoas Muscle	Psoas
19	chr6:150642800-150644800	Enhancers	Placenta	Placenta
20	chr6:150642800-150646600	Enhancers	Adipose Nuclei	Adipose
21	chr6:150643000-150643200	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
22	chr6:150643200-150643600	Enhancers	Fetal Muscle Trunk	muscle
23	chr6:150643200-150643600	Flanking Active TSS	Skeletal Muscle Female	skeletal muscle
24	chr6:150643200-150643600	Enhancers	Spleen	Spleen
25	chr6:150643200-150644800	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
26	chr6:150643200-150646200	Enhancers	Lung	lung
27	chr6:150643400-150644200	Flanking Active TSS	Skeletal Muscle Male	skeletal muscle
28	chr6:150643400-150644600	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
29	chr6:150643600-150643800	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
30	chr6:150643600-150644200	Bivalent Enhancer	Fetal Muscle Trunk	muscle
31	chr6:150643600-150645800	Weak transcription	Spleen	Spleen
32	chr6:150643600-150646800	Enhancers	Skeletal Muscle Female	skeletal muscle
33	chr6:150643800-150648400	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
34	chr6:150644000-150644200	Bivalent Enhancer	HUVEC	blood vessel
35	chr6:150644000-150644600	Enhancers	Placenta Amnion	Placenta Amnion
36	chr6:150644200-150646400	Enhancers	Fetal Muscle Trunk	muscle
37	chr6:150644200-150646800	Enhancers	Skeletal Muscle Male	skeletal muscle
38	chr6:150644400-150644800	Enhancers	Left Ventricle	heart
39	chr6:150644600-150645200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
40	chr6:150644800-150646000	Weak transcription	Left Ventricle	heart
41	chr6:150645000-150647800	Weak transcription	K562	blood
42	chr6:150645200-150645600	ZNF genes & repeats	iPS DF 19.11 Cell Line	embryonic stem cell
43	chr6:150645200-150645600	Enhancers	Cortex derived primary cultured neurospheres	brain
44	chr6:150645200-150645600	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
45	chr6:150645200-150646400	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
46	chr6:150645200-150646800	Enhancers	HMEC	breast
47	chr6:150645200-150647200	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
48	chr6:150645400-150647000	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
49	chr6:150645600-150646400	Enhancers	Primary hematopoietic stem cells	blood
50	chr6:150645600-150646400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links